| CreditFlow: End of Day (Europe IG) | Jun 2, 2026 |
| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Jun 2, 2026 | NOVOB | Novo Nordisk AS | - | AA | - | CHF180 | Sr. Unsecured | 3.00 | - | Jun-29 | 0.575% | IGC | EMEA | ||||
HLTH | PRCD | Jun 2, 2026 | NOVOB | Novo Nordisk AS | - | AA | - | CHF400 | Sr. Unsecured | 6.00 | - | Jun-32 | 0.9425% | IGC | EMEA | ||||
HLTH | PRCD | Jun 2, 2026 | NOVOB | Novo Nordisk AS | - | AA | - | CHF335 | Sr. Unsecured | 10.00 | - | Jun-36 | 1.315% | IGC | EMEA | ||||
HLTH | PRCD | Jun 2, 2026 | NOVOB | Novo Nordisk AS | - | AA | - | CHF175 | Sr. Unsecured | 15.00 | - | Jun-41 | 1.6325% | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €650 | Sr. Unsecured | 2.00 | - | Nov-27 | 3mEu+20 | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €650 | Sr. Unsecured | 3.25 | - | Feb-29 | 2.50% | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €600 | Sr. Unsecured | 6.25 | - | Feb-32 | 3.00% | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €600 | Sr. Unsecured | 9.25 | - | Feb-35 | 3.375% | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €750 | Sr. Unsecured | 12.25 | - | Feb-38 | 3.625% | IGC | EMEA | ||||
HLTH | PRCD | Nov 13, 2025 | NOVOB | Novo Nordisk Finance (Netherlands) BV | Aa3 | AA | - | €750 | Sr. Unsecured | 20.00 | - | Nov-45 | 4.00% | IGC | EMEA |